Search
 

From Tech to Biotech

Gilead CFO Robin Washington has overseen an ERP implementation and the company's $111 billion acquisition of Pharmasset.

By John Hintze | Updated on June 01, 2012
Robin Washington was a veteran of technology companies when she joined Gilead Sciences as CFO in May 2008, shortly before the financial markets imploded. Since then, she’s led the biopharmaceutical company through a major ERP implementation and one of biotech’s biggest acquisitions.

Washington was previously controller at enterprise software provider PeopleSoft, where she was positioned to take over as CFO when the company was acquired by Oracle in 2004. Washington then signed on as CFO at Hyperion Solutions, but Hyperion was also acquired by Oracle. Washington decided it was time to consider opportunities in some fast-growing industry outside of enterprise software.

When she was approached by Gilead, Washington remembered that her last science class had been high school biology. Nevertheless, she took the challenge. Although she recalls digging in to understand Gilead’s business as one of the top challenges in her career, “the great thing about finance is that the skill set is very transferable,” she says.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.

Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Recommended Stories

Why Companies Are Racing to the U.S. Debt Market

Why Companies Are Racing to the U.S. Debt Market

Caleb Mutua & Jeannine Amodeo |

Borrowing costs have become compelling, as markets are already pricing in expectations for reduced interest rates. And several external factors could reverse that trend.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2024 ALM Global, LLC. All Rights Reserved.